Skip to content

Menu
  • USC Stem Cell
  • About
    • Stem Cell FAQs
    • Mission and History
    • California’s Leadership in Stem Cell Research
    • Founding Supporters and Ambassadors
    • Well-being
    • Jobs
  • News & Events
    • News
    • Events
    • Videos
    • Impact Reports and Newsletters
  • Research
    • Department Faculty
    • Eli and Edythe Broad Center Faculty
    • Research Facilities
    • USC+CHLA Alpha Clinic
    • Translational Research Committee
    • USC Stem Cell Research Oversight Committee (SCRO)
    • Apply to Become Center Faculty
  • Education & Training
    • Undergraduate
    • Master’s Program
    • PhD Program
    • Medical Education
    • Postdoctoral Opportunities
    • Our Trainees
  • Funding
  • Inclusive Excellence
  • Support Us
  • Contact
    • Directory
    • Subscribe
  • Search

USC rolls out the cardinal carpet for the new president of California’s stem cell agency

By  Cristy Lytal

Posted June 26, 2014
Reading Time 3 minutes

in this section

  • News
  • Events
  • Videos
  • Impact Reports and Newsletters

read this next

Stem cells won the heart of clinical trial participant Fred Lesikar. (Photo by Cristy Lytal)

USC hosts California stem cell agency’s tenth birthday bash

  • Follow us on
  • Like us on
  • Follow us on
  • Follow us on
CIRM President C. Randal Mills (left) (Photo by Gerald Devotta)
CIRM President C. Randal Mills (left) (Photo by Gerald Devotta)

“I will be beating the better, faster drum as long as there are patients that need to be treated,” said C. Randal Mills, the newly appointed president and chief executive officer of the California Institute for Regenerative Medicine (CIRM), at a June 10 public appearance at USC.

Researchers, industry leaders, patient advocates and curious members of the public gathered to hear Mills share this vision at the Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC.

As the new leader of CIRM — established in 2004 to dispense $3 billion in voter-approved dollars to fund stem cell research in California — Mills outlined four simple principles to guide the agency’s decisions about which projects to support.

“The first test is that it has to accelerate the development of a stem cell therapy to a patient,” he said. “Part two is that it has to increase the likelihood of success of a stem cell treatment. The third criteria is that there has to be an unmet medical need. And then fourth is [that it has to do so] efficiently.”

Mills, who has been a member of CIRM’s Grant Review Board for the past five years, was previously the president and CEO of Osiris Therapeutics, the first company to commercialize a stem cell drug, used to treat children with a potentially lethal complication of bone marrow transplantation.

“We developed a saying at Osiris, which is: ‘Work like someone’s life depends on it, because someone’s life depends on it.’ And that is also what we do here at CIRM,” he said.

Prior to Osiris, Mills held leadership positions at RTI Biologics Inc., the University of Florida Tissue Bank, and the American Association of Tissue Banks’ Standards Committee. The U.S. Secretary of Health and Human Services appointed him as a voting member of the National Institutes of Health and AIDS Research Advisory Council. He holds a bachelor’s degree in microbiology and cell science and a PhD in drug development from the University of Florida.

Mills is replacing Alan Trounson, who stepped down from the CIRM presidency after six years to spend more time with his family in Australia.

“To say we are delighted to have Randy take over as president is an understatement,” said Jonathan Thomas, chairman of CIRM’s Governing Board. “He is a well-respected scientist whose experience and expertise will ensure we will continue to be a world leader in stem cell research.”

Read more about: Education

Post navigation

← Fasting triggers stem cell regeneration of damaged, old immune system
Mark Humayun and David Hinton look to stem cells to bring sight to the blind →
Keck School of Medicine of USC
1975 Zonal Ave.
Los Angeles, CA 90033
Google Map
Phone: (323) 442-1900
Hours:
Monday–Friday
7:30am–5:00pm PST
Resources For
  • Current Students
  • Faculty & Staff
  • Patients
  • Community
  • Press
  • Visitors
Areas of Focus
  • Education & Training
  • Research
  • Patient Care
  • Community
Departments and Offices
  • Departments
  • Institutes and Centers
  • Research Programs
  • Administrative Offices
About Keck
  • History
  • Leadership
  • Annual Report
  • Digital Accessibility
Intranet
  • Privacy Notice
  • Notice of Non-Discrimination
  • Smoke-Free Policy

Copyright © 2025 University of Southern California

  • Research
    • Research HomeCutting-edge research drives innovation in healthcare at the Keck School of Medicine
    • Where Research Happens
    • Research Funding
    • Training and Education
    • Researcher Resources
    • Collaborate and Partner
  • Education
    • Education HomeNurturing future healthcare leaders through excellence in education
    • MD Program
    • Residencies and Clinical Fellowships
    • PhD Programs
    • Master’s Programs
    • Professional Programs
    • Post-Doctoral Researchers
    • CME, Certificate & Undergraduate Programs
  • Departments, Institutes & Centers
    • Basic Science and Clinical DepartmentsExploring foundational science and specialized clinical fields
    • Institutes and Centers
    • Research Programs
  • About
    • About the Keck SchoolDiscover the mission, history, and vision of the Keck School of Medicine
    • History
    • Leadership
    • Dean’s Corner
    • Life in Southern California
    • Visit
  • Our Faculty
  • Current Students
  • Newsroom
  • Events Calendar
  • Support the Keck School
  • USC.edu
  • Are you a Patient?